Effects of 60-day-6° Head-down Bed Rest on Cartilage and Function of the Knee Joint
1 other identifier
interventional
26
1 country
1
Brief Summary
Objective: To investigate the effects of long-term simulated unloading in bed on articular cartilage quality based on functional magnetic resonance imaging (FMRI) and Knee joint function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2023
CompletedFirst Submitted
Initial submission to the registry
September 19, 2024
CompletedFirst Posted
Study publicly available on registry
September 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2024
CompletedSeptember 25, 2024
August 1, 2024
1.2 years
September 19, 2024
September 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
T2 mapping
metabolic and microstructural changes within the articular cartilage matrix components can be assessed, reflecting collagen fiber structure integrity and water content within the tissue
three days before the HDBR started and three days after the HDBR ended
Secondary Outcomes (2)
Y-balance test
three days before the HDBR started and three days after the HDBR ended
International Knee Documentation Committee (IKDC) scores
three days before the HDBR started and three days after the HDBR ended
Study Arms (1)
Long term bed rest intervention group
EXPERIMENTAL60-day-6° head-down bed rest
Interventions
Throughout the bed rest period, subjects carried out all activities of daily living-eating, voiding, recreation, and testing
Eligibility Criteria
You may qualify if:
- (1) male; (2) age 25-50 years old; (3) height between 160-175 cm, weight ≥50kg, and BMI between 18.5-26 kg/m²; (4) good general health status.
You may not qualify if:
- (1) history of alcoholism; (2) smoking ≥5 cigarettes/day in the 3 months before the test; (3) drug dependence or use of medications affecting bone metabolism within 2 weeks before screening; (4) presence of metal implants, severe vertigo, or severe snoring.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, China
Study Officials
- STUDY CHAIR
Jianquan Wang, M.D.
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2024
First Posted
September 25, 2024
Study Start
September 10, 2023
Primary Completion
November 10, 2024
Study Completion
November 15, 2024
Last Updated
September 25, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share